|
|
|
|
|
|
|
|
Cheng Li Lab of Computational Cancer Genomics
Research Interests How do genomic changes in the cell promote cancer initiation and progression, and can be used to predict patient response and prognosis? We are developing analysis models and software for high-throughput sequencing and microarray data, and working with biologists and clinicians to study genomics, expression, and network changes in cancer cells towards novel drug targets. We have provided the new analysis methods through user-friendly software such as the widely-used dChip (cited 2000 times) and ComBat (cited 80 times).
Research Support National Institutes of Health, Claudia Adams Barr Program, and Friends of DFCI.
Address Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute #11036, Center for Life Sciences, 3 Blackfan Circle, Boston, MA 02115 Cheng Li: Email lch3000@gmail.com, Phone 617-632-3498 Up-to-date webpage: www.ChengLiLab.org
|
|
|
|
